MedPath

The Perspective of Healthy Individuals on Breast Cancer Risk Prediction Report In The Indonesian Population

Not Applicable
Completed
Conditions
Breast Cancer
Interventions
Other: Focus Group Discussion
Registration Number
NCT05562440
Lead Sponsor
Nalagenetics Pte Ltd
Brief Summary

In 2016, a meta-analysis showed that DNA-based risk reporting alone does not facilitate behavior change. However, there have been several studies showing that tailoring care plans related to diet may help with adherence to a tailored diet plan.

Risk prediction report displays both Polygenic Risk Score (PRS) and modifiable (non-genetic) risk factors. Overtime, the investigators aim to combine both PRS and modifiable risk factors to have a localized and stronger prediction model for the local population. The risk prediction report is designed to tailor care plans for patients by their physicians or care planner.

Focus groups allow deeper discussions in themes important to guide design of the report. This method has been used in previous similar studies, such as one by Cutting et al to understand physicians' preference in integrating genetic reports into daily practice. Studies also have shown that local adoption of personalized medicine and care is hindered by limited infrastructure of information management and awareness, despite personalized medicine being widely adopted in healthcare systems in developing countries.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
10
Inclusion Criteria
  1. Female
  2. Able to give informed consent
  3. Aged 25-75 years old
  4. Have access to a mobile phone or computer with the Zoom application or a caregiver who is able to assist them with the Zoom application
Exclusion Criteria
  1. Ever diagnosed with breast cancer

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Focus Group Discussion on breast cancer risk prediction reportFocus Group DiscussionWoman population with no breast cancer who received the dummy report result
Primary Outcome Measures
NameTimeMethod
Focus Group DiscussionsImmediately after exposure to dummy report

To qualitatively investigate participants' perceptions and gather their feedbacks on the clarity, completeness, and their impressions towards the breast cancer risk prediction dummy report. FGD will be transcribed and analyzed using thematic analysis method.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

MRCCC Siloam Hospitals Semanggi

🇮🇩

Jakarta, DKI Jakarta, Indonesia

© Copyright 2025. All Rights Reserved by MedPath